Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2025-12-26 @ 1:49 AM
Study NCT ID:
NCT01355705
Status:
COMPLETED
Last Update Posted:
2018-09-18
First Post:
2011-05-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Sponsor:
Michaela Liedtke
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-16
First Submit QC Date:
None
Study First Post Date:
2011-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-11
Results First Submit QC Date:
None
Results First Post Date:
2017-03-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-17
Last Update Post Date:
2018-09-18
Last Update Post Date Type:
ACTUAL